Increased albuminuria in 4-year-old preterm-born children with normal height

Rachel Vieux1, Jean-Michel Hascoët, Patricia Franck

  • 1Neonatal Department, Nancy, France. r.vieux@maternite.chu-nancy.fr

The Journal of Pediatrics
|January 21, 2012
PubMed

Insights

Preterm-born children with normal height at age 4 may face higher risks for kidney damage, specifically glomerulosclerosis. This finding highlights the importance of monitoring kidney health in this vulnerable population.

Area of Science:

  • Pediatric Nephrology
  • Neonatal Medicine
  • Public Health

Background:

  • Preterm birth is associated with long-term health risks, including potential kidney complications.
  • Early identification of risk factors for hypertension and kidney dysfunction in preterm infants is crucial for timely intervention.

Purpose of the Study:

  • To investigate risk factors for elevated blood pressure (BP), glomerulosclerosis, and tubular dysfunction in 4-year-old children born preterm.
  • To identify predictors of kidney health markers at age 4 in a cohort of preterm-born children.

Main Methods:

  • A longitudinal cohort study involving 119 preterm-born children.
  • Measurements of BP, albuminuria, and β2 microglobulin were collected during the neonatal period and at 4 years of age.

Main Results:

  • 12.6% of 4-year-olds had elevated systolic BP (>95th percentile).
  • Children with height <-1 SD had lower BP; however, normal height at age 4 was linked to increased albuminuria.
  • Female sex and normal height at age 4 were independently associated with higher albuminuria levels, indicating potential glomerulosclerosis.

Conclusions:

  • Normal height at 4 years of age may signal an increased risk for glomerulosclerosis in preterm-born children.
  • These findings underscore the need for continued monitoring of renal health in children born preterm, particularly those with normal stature at preschool age.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.